BeStock  
Stocks › Biotechnology › ZVRA

Zevra Therapeutics ZVRA

US equityMarket cap rank #3557Biotechnology
$11.08 +$0.35 (+3.26%)
Pre-market · Oct 8, 7:00 am ET · After hours $11.19 +0.99%
Open$10.68
Prev close$10.73
Day range$10.57 – $11.38
Volume936.5K
Market cap$657.97M
P/E (TTM)11.9
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$39.66M+53.3% YoY
Operating profit$16.78M+236.1% YoY
Net profit$8.75M-88.3% YoY
Diluted EPS$0.14-88.4% YoY
Free cash flow$16.82M+540.9% YoY
Operating cash flow$17.03M

Revenue, last 8 quarters

$3.7MSep '24$12.0MDec '24$20.4MMar '25$25.9MJun '25$26.1MSep '25$34.1MDec '25$36.2MMar '26$39.7MJun '26

Net profit, last 8 quarters

$-33.2MSep '24$-35.7MDec '24$-3.1MMar '25$74.7MJun '25$-544.0KSep '25$12.2MDec '25$37.9MMar '26$8.8MJun '26

Diluted EPS by quarter

-0.69Sep '24-0.69Dec '24-0.06Mar '251.21Jun '25-0.01Sep '250.19Dec '250.60Mar '260.14Jun '26

Free cash flow by quarter

$-18.1MSep '24$-16.3MDec '24$-8.3MMar '25$-3.8MJun '25$4.2MSep '25$5.5MDec '25$6.1MMar '26$16.8MJun '26

Annual revenue

$13.3MFY20$28.7MFY21$10.2MFY22$27.5MFY23$23.6MFY24$106.5MFY25

Profitability & balance sheet

Gross margin95.5%
Operating margin28.7%
Net margin42.8%
Return on equity34.8%
Return on assets20.8%
Return on invested capital27.3%
Current ratio5.17
Liabilities / assets28.1%
Cash & investments$221.57M
Total debt$870,000.00
Net cash (debt)$220.70M
Free cash flow / sales24.0%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $39.66M $36.22M $106.47M $34.13M $26.06M
Total Operating Revenue $39.66M $36.22M $106.47M $34.13M $26.06M
Cost of Revenue $1.53M $1.90M $16.48M $1.52M $1.24M
Gross Profit $38.14M $34.32M $89.99M $32.61M $24.83M
Operating Expense $21.36M $25.49M $94.22M $23.29M $20.68M
Selling and Admin Expenses $16.56M $20.78M $77.62M $20.35M $16.94M
Research & Development $4.49M $4.39M $12.74M $2.62M $3.43M
Depreciation & Amortization & Depletion $316,000.00 $316,000.00 $3.86M $316,000.00 $315,000.00
-Depreciation & Amortization $316,000.00 $316,000.00 $3.86M $316,000.00 $315,000.00
Operating Profit $16.78M $8.83M -$4.23M $9.32M $4.14M
Net Non-Operating Interest Income (Expense) $2.57M $1.88M -$1.03M -$236,000.00 $262,000.00
Non-Operating Interest Income $2.57M $3.59M $6.95M $1.71M $2.31M
Non-Operating Interest Expense $0.00 $1.71M $7.98M $1.95M $2.05M
Other Income (Expense) -$6.55M $34.09M $91.94M $3.59M -$5.38M
Gain on Sale of Security -$6.55M -$6.46M $2.33M $3.59M -$5.38M
Special Income (Charges) $0.00 $40.56M $89.62M $0.00 $0.00
-Less:Impairment of Capital Assets $0.00 – $58.71M $0.00 $0.00
-Gain on Sale of Property/Plant/Equipment $0.00 $43.31M $148.33M $0.00 $0.00
Pretax Profit $12.79M $44.80M $86.68M $12.67M -$977,000.00
Tax $4.04M $6.91M $3.45M $501,000.00 -$433,000.00
Net Profit $8.75M $37.89M $83.23M $12.17M -$544,000.00
Profit from Continuing Operations $8.75M $37.89M $83.23M $12.17M -$544,000.00
Net Income to Parent Company $8.75M $37.89M $83.23M $12.17M -$544,000.00
Net Income to Common Stockholders $8.75M $37.89M $83.23M $12.17M -$544,000.00
Basic EPS $0.14 $0.62 $1.40 $0.20 -$0.01
Diluted EPS $0.14 $0.60 $1.35 $0.19 -$0.01
-Less:Other Special Charges – $2.76M – – –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $302.71M $278.58M $284.73M $284.73M $270.12M
Total Current Assets $251.30M $229.97M $223.01M $223.01M $225.12M
Cash and Cash Equivalents & Short-Term Investments $221.57M $200.62M $191.01M $191.01M $199.51M
-Cash and Cash Equivalents $145.32M $95.60M $62.41M $62.41M $54.44M
-Short Term Investments $76.25M $105.02M $128.61M $128.61M $145.07M
Receivables $22.49M $22.10M $23.26M $23.26M $16.84M
-Accounts Receivable $10.33M $7.65M $9.88M $9.88M $8.77M
-Other Receivables $12.16M $14.45M $13.38M $13.38M $8.07M
Inventory $2.45M $2.31M $1.74M $1.74M $1.37M
Other Current Assets $4.79M $4.94M $6.05M $6.05M $7.40M
Total Non-Current Assets $51.41M $48.61M $61.72M $61.72M $45.00M
Net PPE $2.31M $1.52M $1.70M $1.70M $1.83M
-Gross PPE $2.31M $1.52M $2.02M $2.02M $1.83M
Investments and Advances $38.61M $36.15M $47.88M $47.88M $30.87M
-Available for Sale Securities $38.61M $36.15M $47.88M $47.88M $30.87M
Goodwill and Other Intangible Assets $10.49M $10.81M $11.12M $11.12M $11.44M
-Goodwill $4.70M $4.70M $4.70M $4.70M $4.70M
-Other Intangible Assets $5.79M $6.11M $6.42M $6.42M $6.74M
Other Non-Current Assets $3,000.00 $143,000.00 $1.02M $1.02M $873,000.00
Total Liabilities $85.06M $72.78M $130.07M $130.07M $136.95M
Total Current Liabilities $48.63M $47.03M $39.28M $39.28M $26.11M
Payables $34.81M $32.04M $16.19M $16.19M –
-Accounts Payable $13.96M $11.69M $2.48M $2.48M –
-Total Tax Payable $20.84M $20.35M $13.71M $13.71M –
Short-Term Debt and Capital Lease Obligation $626,000.00 $406,000.00 $419,000.00 $419,000.00 $441,000.00
-Current Capital Lease Obligation $626,000.00 $406,000.00 $419,000.00 $419,000.00 $441,000.00
Other Current Liabilities $13.20M $14.58M $13.55M $13.55M $14.60M
Total Non-Current Liabilities $36.43M $25.75M $90.80M $90.80M $110.84M
Long Term Accounts Payable and Other Payables $7.21M $6.87M $7.03M $7.03M $17.46M
Long Term Debt and Capital Lease Obligation $870,000.00 $741,000.00 $62.79M $62.79M $62.28M
-Long Term Capital Lease Obligation $870,000.00 $741,000.00 $859,000.00 $859,000.00 $966,000.00
Derivative Product Liabilities $13.17M $6.80M $9.58M $9.58M $13.77M
Other Non-Current Liabilities $15.19M $11.34M $11.41M $11.41M $17.33M
Total Equity $217.65M $205.80M $154.66M $154.66M $133.17M
Stockholders' Equity $217.65M $205.80M $154.66M $154.66M $133.17M
Capital Stock $6,000.00 $6,000.00 $6,000.00 $6,000.00 $6,000.00
-Common Stock $6,000.00 $6,000.00 $6,000.00 $6,000.00 $6,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $606.26M $602.75M $588.46M $588.46M $580.78M
Retained Earnings -$375.42M -$384.17M -$422.06M -$422.06M -$434.23M
Less: Treasury Stock $10.98M $10.98M $10.98M $10.98M $10.98M
Gains/Losses Not Affecting Retained Earnings -$2.22M -$1.80M -$764,000.00 -$764,000.00 -$2.42M
Prepaid Assets – – $946,000.00 $946,000.00 –
-Accumulated Depreciation – – -$314,000.00 -$314,000.00 –
Current Accrued Expenses – – $9.12M $9.12M –
-Long Term Debt – – $61.93M $61.93M $61.31M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $17.03M $6.14M -$1.60M $5.52M $4.71M
Net cash flow from continuing operations $17.03M $6.14M -$1.60M $5.52M $4.71M
Net Income from Continuing Operations $8.75M $37.89M $83.23M $12.17M -$544,000.00
Gain/Loss from Continuing Operations $6.00M -$35.71M -$148.89M -$2.07M $5.50M
Depreciation & Depletion & Amortization $364,000.00 $368,000.00 $4.05M $362,000.00 $392,000.00
Deferred Tax $703,000.00 $6.91M $3.45M $501,000.00 -$433,000.00
Other Non-Cash Items -$377,000.00 -$12.95M $3.33M $1.21M $685,000.00
Change in Working Capital -$926,000.00 $9.59M -$26.51M -$10.05M -$2.33M
-Change in Receivables -$5.74M $6.89M -$11.98M -$6.37M $1.36M
-Change in Inventory -$140,000.00 -$185,000.00 -$1.31M -$525,000.00 -$194,000.00
-Change in Prepaid Assets $149,000.00 $2.05M -$2.94M $399,000.00 -$3.05M
-Change in Payables and Accrued Expense $2.32M -$529,000.00 -$15.59M $412,000.00 -$4.73M
-Change in Other Current Assets -$102,000.00 -$87,000.00 $451,000.00 -$25,000.00 $1.27M
-Change in Other Current Liabilities $280,000.00 $293,000.00 -$1.83M -$6.11M $4.85M
-Change In Other Working Capital $2.31M $1.15M $6.68M $2.17M -$1.84M
Net cash flow from investing $31.45M $79.62M $18.13M $227,000.00 -$4.58M
Net Cash Flow from Continuing Investing Activities $31.45M $79.62M $18.13M $227,000.00 -$4.58M
Net PPE Purchase and Sale -$259,000.00 $7,000.00 -$387,000.00 -$110,000.00 $35,000.00
Net Intangibles Purchase and Sale $5.00M $43.94M – – –
Net Investment Purchase and Sale $26.71M $35.68M $18.51M $337,000.00 $145.39M
Financing Cash Flow $1.59M -$52.80M $12.06M $2.55M $6.53M
Net Cash Flow from Continuing Financing Activities $1.59M -$52.80M $12.06M $2.55M $6.53M
Net Issuance Payments Of Debt $0.00 -$60.09M $0.00 $0.00 $0.00
Proceeds from Stock Option Exercised $435,000.00 $9.92M $3.80M -$6.09M $6.53M
Net Other Financing Charges $1.15M -$2.64M -$372,000.00 $0.00 $0.00
Ending Cash Balance $145.32M $95.60M $62.41M $62.41M $54.44M
Net Change in Cash $50.07M $32.96M $28.59M $8.29M $6.66M
Beginning Cash Balance $95.60M $62.41M $33.79M $54.44M $47.71M
Effect of Exchange Rate Changes -$342,000.00 $233,000.00 $28,000.00 -$322,000.00 $64,000.00
Free Cash Flow $16.82M $6.11M -$2.43M $5.55M $4.16M
Net Common Stock Issuance – – $8.64M $8.64M –

Discussion

No comments yet — be the first to weigh in on ZVRA.

Leave a comment

Scroll to Top